The OPTIMAX first-in-man study Mid-term clinical outcome of Titanium-Nitride-Oxidecoated Cobalt Chromium stents in patients with de novo coronary artery lesions

Facebooktwitterredditpinterestlinkedinmail

PDF Presentation

Optimax-FIM-PCR-2014